TABLE 4.
Cost-effectiveness of clopidogrel
Patients | Δcost, $ | Δlost life-years | ICERlyg, $ | Per cent dominant | Per cent dominated | Per cent <$20,000/lyg |
---|---|---|---|---|---|---|
CURE | 263 | 0.0682 | $3,856 | 9.1 | 0.5 | 97.5 |
PCI-CURE | 333 | 0.0885 | $3,763 | 16.6 | 2.9 | 90.4 |
CURE Clopidogrel in Unstable angina to prevent Recurrent Events; ICER Incremental cost-effectiveness ratio; lyg Life-years gained; PCI-CURE Percutaneous Coronary Intervention in CURE